Information  X 
Enter a valid email address

GlobalData PLC (DATA)


Monday 10 January, 2022

GlobalData PLC

Update on FY21 performance and Capital Markets Day

RNS Number : 8995X
GlobalData PLC
10 January 2022

10 January 2022

GlobalData Plc

Update on FY21 performance and Capital Markets Day

Ahead of the full-year results, GlobalData Plc ("GlobalData" or the "Company", and together with its subsidiaries, the "Group"), the leading provider of industry intelligence, confirms that it expects to report another year of strong organic growth driven by its continued momentum in subscription revenue and further expansion of EBITDA margin.

For FY21, the Board expects like-for-like organic revenue growth1 to be ~8%, with currency volatility offsetting some gains to finish on revenue ~£189m, at an Adjusted EBITDA margin of ~34% (2020: 32%) (which is within the consensus range2). Invoiced Forward Revenue3 is expected to finish with like-for-like organic growth of ~9%.

GlobalData's strong organic growth is augmented with the strategic progress made through M&A in the last quarter of FY21, with the acquisitions of the Life Sciences business of IHS Markit, LMCA Holdings Limited and LMCI Holdings Limited. Whilst the timing of the acquisitions meant that the financial impact on FY21 was immaterial, the strengthening of the Group's capabilities in the Life Sciences, Automotive and Agribusiness sectors give it greater scale and opportunity for accelerated momentum in 2022.

The Group also announces that it will be hosting a Capital Markets Event for institutional investors and analysts on 27 January 2022. Should you wish to wish to attend, please register by emailing [email protected] . No new material financial or trading information will be disclosed during the event.

The Group will publish its full-year results on 28 February 2022.

Mike Danson, Chief Executive Officer, said:

"I am pleased to report that we expect our FY21 results to demonstrate further momentum and that we are on track to report another year of strong revenue growth and Adjusted EBITDA margin expansion.

Additionally, the two strategic acquisitions that we completed in the latter part of the year, mean that we enter 2022 with enhanced scale and additional capabilities. I would like to, again, take this opportunity to welcome all our new colleagues and I look forward to presenting our strategic update at the Capital Market Event on 27 January."



This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon publication of this announcement, this inside information is now considered to be in the public domain.

(1)  Like-for-like organic growth excludes the impact of currency movements and the benefit of acquisitions in the year.

(2)  The company compiled consensus range for the year ended 31 December 2021 (FY21) is £188m to £190.3m for revenue and £63.5m to £64.5m for Adjusted EBITDA.

(3)  Invoiced Forward Revenue relates to amounts that are invoiced to clients at the balance sheet date, which relate to future revenue to be recognised.



GlobalData Plc  


Mike Danson, Chief Executive Officer

Graham Lilley, Chief Financial Officer 

0207 936 6400




Bill Hutchings/ Mose Adigun - J.P. Morgan Cazenove (Nomad and joint broker)

0207 742 4000

Erik Anderson/ Alina Vaskina - Panmure Gordon (Joint Broker)                                     

020 7886 2500

Hudson Sandler 


Nick Lyon

0207 796 4133


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t